HB3785Introduced in the House
Relating to labeling requirements for compounded drug products.
Introduced by Barbara Gervin-Hawkins, District 120
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Relating to labeling requirements for compounded drug products.
Where it stands
Failed to receive affirmative vote in comm.
April 28, 2025
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Filed
Read first time
Referred to Public Health
Scheduled for public hearing on . . .
Considered in public hearing
Testimony taken/registration(s) recorded in committee
Left pending in committee
Considered in public hearing
Committee substitute considered in committee
Failed to receive affirmative vote in comm.
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.